• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑肿瘤中的癌组蛋白:土壤与种子。

Oncohistones in brain tumors: the soil and seed.

机构信息

Department of Human Genetics, McGill University, Montreal, QC, H3A 0C7, Canada.

Department of Human Genetics, McGill University, Montreal, QC, H3A 0C7, Canada; Department of Pediatrics, McGill University, Montreal, QC, H3A 0C7, Canada; The Research Institute of the McGill University Health Centre, Montreal, QC, H4A 3J1, Canada.

出版信息

Trends Cancer. 2023 May;9(5):444-455. doi: 10.1016/j.trecan.2023.02.003. Epub 2023 Mar 16.

DOI:10.1016/j.trecan.2023.02.003
PMID:36933956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11075889/
Abstract

Recurrent somatic mutations in histone 3 (H3) variants (termed 'oncohistones') have been identified in high-grade gliomas (HGGs) in children and young adults and induce tumorigenesis through disruption of chromatin states. Oncohistones occur with exquisite neuroanatomical specificity and are associated with specific age distribution and epigenome landscapes. Here, we review the known intrinsic ('seed') and the extrinsic ('soil') factors needed for their optimal oncogenic effect and highlight the many unresolved questions regarding their effects on development and crosstalk with the tumor microenvironment. The 'seed and soil' analogy, used to explain tumor metastatic niches, also applies to oncohistones, which mainly thrive and flourish in specific chromatin states during very narrow windows of development, creating exquisite vulnerabilities, which could provide effective therapies for these deadly cancers.

摘要

组蛋白 3(H3)变体(称为“癌组蛋白”)的复发性体细胞突变已在儿童和年轻成人的高级别神经胶质瘤(HGG)中被鉴定出来,并通过破坏染色质状态诱导肿瘤发生。癌组蛋白具有精细的神经解剖学特异性,与特定的年龄分布和表观基因组景观相关。在这里,我们回顾了已知的内在(“种子”)和外在(“土壤”)因素,这些因素对于它们的最佳致癌效应是必需的,并强调了许多关于它们对发育的影响和与肿瘤微环境相互作用的未解决问题。用于解释肿瘤转移龛的“种子和土壤”类比也适用于癌组蛋白,癌组蛋白主要在发育的非常狭窄的窗口期间在特定的染色质状态中茁壮成长,从而产生精细的脆弱性,这可能为这些致命癌症提供有效的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c573/11075889/bf33357364ee/nihms-1982761-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c573/11075889/785fb2eae5c7/nihms-1982761-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c573/11075889/caad0fc76284/nihms-1982761-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c573/11075889/131ac0cd1a2c/nihms-1982761-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c573/11075889/bf33357364ee/nihms-1982761-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c573/11075889/785fb2eae5c7/nihms-1982761-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c573/11075889/caad0fc76284/nihms-1982761-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c573/11075889/131ac0cd1a2c/nihms-1982761-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c573/11075889/bf33357364ee/nihms-1982761-f0004.jpg

相似文献

1
Oncohistones in brain tumors: the soil and seed.脑肿瘤中的癌组蛋白:土壤与种子。
Trends Cancer. 2023 May;9(5):444-455. doi: 10.1016/j.trecan.2023.02.003. Epub 2023 Mar 16.
2
Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.癌组蛋白与小儿型弥漫性高级别神经胶质瘤中的发育紊乱。
Cancer Metastasis Rev. 2023 Jun;42(2):367-388. doi: 10.1007/s10555-023-10105-2. Epub 2023 Apr 29.
3
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.组蛋白 H3.3G34 突变的中间神经元祖细胞借助 PDGFRA 促进神经胶质瘤发生。
Cell. 2020 Dec 10;183(6):1617-1633.e22. doi: 10.1016/j.cell.2020.11.012. Epub 2020 Nov 30.
4
Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors.携带组蛋白 H3.3 突变的神经胶质瘤的碱基分辨率甲基组图谱揭示了与骨肿瘤共享的 G34 突变体特异性特征。
Sci Rep. 2020 Sep 30;10(1):16162. doi: 10.1038/s41598-020-73116-x.
5
Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.H3 G34R 突变型胶质瘤中低级别原浆型形态学和同时存在的 K27M 突变:临床病理特征。
J Neuropathol Exp Neurol. 2020 Oct 1;79(10):1038-1043. doi: 10.1093/jnen/nlaa101.
6
The dark side of histones: genomic organization and role of oncohistones in cancer.组蛋白的黑暗面:基因组组织和癌蛋白在癌症中的作用。
Clin Epigenetics. 2021 Apr 7;13(1):71. doi: 10.1186/s13148-021-01057-x.
7
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism.PFA 室管膜瘤相关蛋白 EZHIP 通过类似于 H3 K27M 的机制抑制 PRC2 活性。
Nat Commun. 2019 May 13;10(1):2146. doi: 10.1038/s41467-019-09981-6.
8
Histone H3 mutations--a special role for H3.3 in tumorigenesis?组蛋白H3突变——H3.3在肿瘤发生中起特殊作用?
Chromosoma. 2015 Jun;124(2):177-89. doi: 10.1007/s00412-015-0510-4. Epub 2015 Mar 14.
9
Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.组蛋白沉积途径决定了 H3.1 和 H3.3 K27M 癌化组蛋白的染色质景观。
Elife. 2020 Sep 9;9:e61090. doi: 10.7554/eLife.61090.
10
Oncohistones: drivers of pediatric cancers.肿瘤组蛋白:儿童癌症的驱动因素
Genes Dev. 2017 Dec 1;31(23-24):2313-2324. doi: 10.1101/gad.309013.117.

引用本文的文献

1
Aberrant EZHIP expression drives tumorigenesis in osteosarcoma.异常的EZHIP表达驱动骨肉瘤的肿瘤发生。
Nat Commun. 2025 Jul 22;16(1):6752. doi: 10.1038/s41467-025-61558-8.
2
An oncohistone-driven H3.3K27M/CREB5/ID1 axis maintains the stemness and malignancy of diffuse intrinsic pontine glioma.一种癌组蛋白驱动的H3.3K27M/CREB5/ID1轴维持弥漫性脑桥内胶质瘤的干性和恶性程度。
Nat Commun. 2025 Apr 17;16(1):3675. doi: 10.1038/s41467-025-58795-2.
3
Coupling deep phenotypic quantification with next-generation phenotyping for 192 individuals with germline histonopathies.

本文引用的文献

1
K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas.K27M 在经典和非经典 H3 变体中发生在脑中线胶质瘤中不同的少突胶质细胞谱系中。
Nat Genet. 2022 Dec;54(12):1865-1880. doi: 10.1038/s41588-022-01205-w. Epub 2022 Dec 5.
2
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location.H3-K27M 突变弥漫性中线胶质瘤在年龄和位置上的肿瘤细胞状态和空间组织景观。
Nat Genet. 2022 Dec;54(12):1881-1894. doi: 10.1038/s41588-022-01236-3. Epub 2022 Dec 5.
3
Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4.
将深度表型定量与下一代表型分析相结合,用于192例种系组织病患者。
HGG Adv. 2025 Apr 15;6(3):100440. doi: 10.1016/j.xhgg.2025.100440.
4
Targeting gut microbiota: a potential therapeutic approach for tumor microenvironment in glioma.靶向肠道微生物群:胶质瘤肿瘤微环境的一种潜在治疗方法。
Front Neurol. 2025 Mar 21;16:1549465. doi: 10.3389/fneur.2025.1549465. eCollection 2025.
5
Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies.小儿大脑半球高级别胶质瘤和 H3.3-G34 突变:对生物学特征和新治疗策略的文献回顾。
Genes (Basel). 2024 Aug 6;15(8):1038. doi: 10.3390/genes15081038.
6
Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals.伴有38例新增个体的神经发育和神经退行性疾病Bryant-Li-Bhoj综合征的扩展表型谱。
Eur J Hum Genet. 2024 Aug;32(8):928-937. doi: 10.1038/s41431-024-01610-1. Epub 2024 Apr 27.
7
Epigenetics to clinicopathological features: a bibliometric analysis of H3 G34-mutant diffuse hemispheric glioma literature.表观遗传学与临床病理特征:H3 G34 突变弥漫性半球胶质瘤文献的文献计量分析。
Childs Nerv Syst. 2024 Jul;40(7):2009-2017. doi: 10.1007/s00381-024-06395-8. Epub 2024 Apr 13.
8
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies.弥漫性脑桥内生型胶质瘤(DIPG):当前及新兴治疗策略综述
Cancer Lett. 2024 May 28;590:216876. doi: 10.1016/j.canlet.2024.216876. Epub 2024 Apr 10.
9
(B)On(e)-cohistones and the epigenetic alterations at the root of bone cancer.(B)单共组蛋白与骨癌根源处的表观遗传改变。
Cell Death Differ. 2025 Jan;32(1):66-77. doi: 10.1038/s41418-023-01227-9. Epub 2023 Oct 12.
10
Complementary roles of EP2 and EP4 receptors in malignant glioma.EP2 和 EP4 受体在恶性脑胶质瘤中的互补作用。
Br J Pharmacol. 2023 Oct;180(20):2623-2640. doi: 10.1111/bph.16148. Epub 2023 Jun 28.
H3.3K27M 突变导致的表观基因组编程导致小儿神经胶质瘤依赖于 SMARCA4。
Cancer Discov. 2022 Dec 2;12(12):2906-2929. doi: 10.1158/2159-8290.CD-21-1492.
4
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma.BAF 复合物维持儿童 H3K27M 脑胶质瘤中的神经胶质瘤干细胞。
Cancer Discov. 2022 Dec 2;12(12):2880-2905. doi: 10.1158/2159-8290.CD-21-1491.
5
Disconnecting multicellular networks in brain tumours.断开脑肿瘤中的细胞间网络连接
Nat Rev Cancer. 2022 Aug;22(8):481-491. doi: 10.1038/s41568-022-00475-0. Epub 2022 Apr 29.
6
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.用于 H3K27M 突变型弥漫性中线脑胶质瘤的 GD2-CAR T 细胞疗法。
Nature. 2022 Mar;603(7903):934-941. doi: 10.1038/s41586-022-04489-4. Epub 2022 Feb 7.
7
Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marks.组蛋白 H3.3 K27M 和 K36M 突变通过扰乱拮抗染色质标记来解除转座元件的抑制。
Mol Cell. 2021 Dec 2;81(23):4876-4890.e7. doi: 10.1016/j.molcel.2021.10.008. Epub 2021 Nov 4.
8
Histone H3.3 G34-mutant Diffuse Gliomas in Adults.成人组 H3.3 G34 突变型弥漫性神经胶质瘤。
Am J Surg Pathol. 2022 Feb 1;46(2):249-257. doi: 10.1097/PAS.0000000000001781.
9
Simultaneous disruption of PRC2 and enhancer function underlies histone H3.3-K27M oncogenic activity in human hindbrain neural stem cells.同时破坏 PRC2 和增强子功能是组蛋白 H3.3-K27M 癌基因在人后脑神经干细胞中的致癌活性的基础。
Nat Genet. 2021 Aug;53(8):1221-1232. doi: 10.1038/s41588-021-00897-w. Epub 2021 Jul 22.
10
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis.局部区域性输注 HER2 特异性 CAR T 细胞治疗儿童和青年复发性或难治性中枢神经系统肿瘤:一项中期分析。
Nat Med. 2021 Sep;27(9):1544-1552. doi: 10.1038/s41591-021-01404-8. Epub 2021 Jul 12.